If we could validate this conclusion from multiple clinical data or conduct some prospective studies, simultaneously including more clinical features related to prostate cancer, such as the relationship between different drug treatments and the expression level of PRGs, this article will be more substantial. The gene discussed is GART; the disease is Familial prostate cancer.